Long-Term Results and Complications of Intracavitary Bacillus Calmette-Guerin Therapy for Bladder Cancer
1984; Lippincott Williams & Wilkins; Volume: 132; Issue: 3 Linguagem: Inglês
10.1016/s0022-5347(17)49690-x
ISSN1527-3792
Autores Tópico(s)Urological Disorders and Treatments
ResumoNo AccessJournal of Urology1 Sep 1984Long-Term Results and Complications of Intracavitary Bacillus Calmette-Guerin Therapy for Bladder Cancer Alvaro Morales Alvaro MoralesAlvaro Morales View All Author Informationhttps://doi.org/10.1016/S0022-5347(17)49690-XAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Clinical studies on intracavitary bacillus Calmette-Guerin therapy for bladder cancer have been conducted at this institution for more than 10 years. The 82 patients treated for prophylaxis of multiple superficial recurrences, residual tumors or carcinoma in situ have been followed for 2 to 7 years after treatment. The long-term results confirm previous studies showing the effectiveness of bacillus Calmette-Guerin in the prophylaxis and therapy of superficial vesical neoplasms. However, some decrease is observed in the population free of disease with a prolonged followup. Recent modifications in the original protocol have been introduced to enhance the effectiveness of the vaccine. Side effects during or shortly after treatment were minor and self-limiting in the large majority of patients (fever, bladder irritability and hematuria). Mild, transient hepatic dysfunction was noted in 2 patients. Hematological disturbances were insignificant. No patient had permanent structural or functional alterations of the bladder © 1984 by The American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetailsCited ByMcKiernan J, Holder D, Ghandour R, Barlow L, Ahn J, Kates M, Badalato G, Roychoudhury A, Decastro G and Benson M (2018) Phase II Trial of Intravesical Nanoparticle Albumin Bound Paclitaxel for the Treatment of Nonmuscle Invasive Urothelial Carcinoma of the Bladder after bacillus Calmette-Guérin Treatment FailureJournal of Urology, VOL. 192, NO. 6, (1633-1638), Online publication date: 1-Dec-2014.McKiernan J, Barlow L, Laudano M, Mann M, Petrylak D and Benson M (2018) A Phase I Trial of Intravesical Nanoparticle Albumin-Bound Paclitaxel in the Treatment of Bacillus Calmette-Guérin Refractory Nonmuscle Invasive Bladder CancerJournal of Urology, VOL. 186, NO. 2, (448-451), Online publication date: 1-Aug-2011.ALI-EL-DEIN B, NABEEH A, ISMAIL E and GHONEIM M (2018) SEQUENTIAL BACILLUS CALMETTE-GUERIN AND EPIRUBICIN VERSUS BACILLUS CALMETTE-GUERIN ALONE FOR SUPERFICIAL BLADDER TUMORS: A RANDOMIZED PROSPECTIVE STUDYJournal of Urology, VOL. 162, NO. 2, (339-342), Online publication date: 1-Aug-1999.Kadhim S, Chin J, Batislam E, Karlik S, Garcia B and Skamene E (2018) Genetically Regulated Response to Intravesical Bacillus Calmette Guerin Immunotherapy of Orthotopic Murine Bladder TumorJournal of Urology, VOL. 158, NO. 2, (646-652), Online publication date: 1-Aug-1997.Chin J, Kadhim S, Batislam E, Karlik S, Garcia B, Nickel C and Morales A (2018) Mycobacterium Cell Wall: An Alternative to Intravesical Bacillus Calmette Guerin (BCG) Therapy in Orthotopic Murine Bladder CancerJournal of Urology, VOL. 156, NO. 3, (1189-1193), Online publication date: 1-Sep-1996.Ali-El Dein B and Nabeeh A (2018) Tuberculous Iliac Lymphadenitis: A Rare Complication of Intravesical Bacillus Calmette-Guerin and Cause of Tumor Over StagingJournal of Urology, VOL. 156, NO. 5, (1766-1767), Online publication date: 1-Nov-1996.Nadler R, Catalona W, Hudson M and Ratliff T (2018) Durability of the Tumor-Free Response for Intravesical Bacillus Calmette-Guerin TherapyJournal of Urology, VOL. 152, NO. 2 Part 1, (367-373), Online publication date: 1-Aug-1994.Morris B, Drazan K, Csete M, Werthman P, Van Bree M, Rosenthal J and Shaked A (2018) Adenoviral-Mediated Gene Transfer to Bladder in VivoJournal of Urology, VOL. 152, NO. 2 Part 1, (506-509), Online publication date: 1-Aug-1994.Hakim S, Heaney J, Heinz T and Zwolak R (2018) Psoas Abscess Following Intravesical Bacillus Calmette-Guerin for Bladder Cancer: A Case ReportJournal of Urology, VOL. 150, NO. 1, (188-189), Online publication date: 1-Jul-1993.Sharpe J, Duffy G and Chin J (2018) Intrarenal Bacillus Calmette-Guerin Therapy for Upper Urinary Tract Carcinoma in SituJournal of Urology, VOL. 149, NO. 3, (457-459), Online publication date: 1-Mar-1993.Soloway M (2018) Editorial CommentJournal of Urology, VOL. 149, NO. 3, (459-460), Online publication date: 1-Mar-1993.Melekos M, Chionis H, Pantazakos A, Fokaefs E, Paranychianakis G and Dauaher H (2018) Intravesical Bacillus Calmette-Guerin Immunoprophylaxis of Superficial Bladder Cancer: Results of a Controlled Prospective Trial with Modified Treatment ScheduleJournal of Urology, VOL. 149, NO. 4, (744-748), Online publication date: 1-Apr-1993.Gonzalez J, Marcol B and Wolf M (2018) Complications of Intravesical Bacillus Calmette-Guerin: A Case ReportJournal of Urology, VOL. 148, NO. 6, (1892-1893), Online publication date: 1-Dec-1992.Böhle A, Kirsten D, Schröder K, Knipper A, Fornara P, Magnussen H and Jocham D (2018) Clinical Evidence of Systemic Persistence of Bacillus Calmette-Guerin: Long-Term Pulmonary Bacillus Calmette-Guerin Infection After Intravesical Therapy for Bladder Cancer and Subsequent CystectomyJournal of Urology, VOL. 148, NO. 6, (1894-1897), Online publication date: 1-Dec-1992.Molina J, Rabian C, D'agay M and Modai J (2018) Hypersen sitivity Systemic Reaction Following Intravesical Bacillus Calmette-Guerin: Successful Treatment With SteroidsJournal of Urology, VOL. 147, NO. 3 Part 1, (695-697), Online publication date: 1-Mar-1992.Morales A, Nickel J and Wilson J (2018) Dose-Response of Bacillus Calmette-Guerin in the Treatment of Superficial Bladder CancerJournal of Urology, VOL. 147, NO. 5, (1256-1258), Online publication date: 1-May-1992.Herr H (2018) Editorial CommentsJournal of Urology, VOL. 147, NO. 5, (1258-1258), Online publication date: 1-May-1992.Lamm D (2018) Editorial CommentsJournal of Urology, VOL. 147, NO. 5, (1258-1258), Online publication date: 1-May-1992.Pagano F, Bassi P, Milani C, Meneghini A, Maruzzi D and Garbeglio A (2018) A Low Dose Bacillus Calmette-Guerin Regimen in Superficial Bladder Cancer Therapy: Is it Effective?Journal of Urology, VOL. 146, NO. 1, (32-35), Online publication date: 1-Jul-1991.Steinberg G, Brendler C, Squire R and Isaacs J (2018) Experimental Intravesical Therapy for Superficial Transitional Cell Carcinoma in a Rat Bladder Tumor ModelJournal of Urology, VOL. 145, NO. 3, (647-653), Online publication date: 1-Mar-1991.Armstrong R (2018) Complications After Intravesical Instillation of Bacillus Calmette-guerin: Rhabdomyolysis and Metastatic InfectionJournal of Urology, VOL. 145, NO. 6, (1264-1266), Online publication date: 1-Jun-1991.Böhle A, Nowc C, Ulmer A, Musehold J, Gerdes J, Hofstetter A and Flad H (2018) Elevations of Cytokines Interleukin-1, Interleukin-2 and Tumor Necrosis Factor in the Urine of Patients after Intravesical Bacillus Calmette-Guerin ImmunotherapyJournal of Urology, VOL. 144, NO. 1, (59-64), Online publication date: 1-Jul-1990.Coplen D, Marcus M, Myers J, Ratliff T and Catalona W (2018) Long-Term Followup of Patients Treated With 1 or 2, 6-Week Courses of Intravesical Bacillus Calmette-Guerin: Analysis of Possible Predictors of Response Free of TumorJournal of Urology, VOL. 144, NO. 3, (652-657), Online publication date: 1-Sep-1990.Deresiewicz R, Stone R and Aster J (2018) Fatal Disseminated Mycobacterial Infection Following Intravesical Bacillus Calmette-GuerinJournal of Urology, VOL. 144, NO. 6, (1331-1333), Online publication date: 1-Dec-1990.Sakamoto G, Burden J and Fisher D (2018) Systemic Bacillus-Calmette Guerin Infection after Transurethral Administration for Superficial Bladder CarcinomaJournal of Urology, VOL. 142, NO. 4, (1073-1074), Online publication date: 1-Oct-1989.Lamm D (2018) Editorial CommentJournal of Urology, VOL. 142, NO. 4, (1074-1075), Online publication date: 1-Oct-1989.Kim H and Lee C (2018) Intravesical Mitomycin C Instillation as a Prophylactic Treatment of Superficial Bladder TumorJournal of Urology, VOL. 141, NO. 6, (1337-1339), Online publication date: 1-Jun-1989.Hardeman S, Perry A and Soloway M (2018) Transitional Cell Carcinoma of the Prostate Following Intravesical Therapy for Transitional Cell Carcinoma of the BladderJournal of Urology, VOL. 140, NO. 2, (289-292), Online publication date: 1-Aug-1988.Herr H and Whitmore W (2018) Ureteral Carcinoma in Situ After Successful Intravesical Therapy for Superficial Bladder Tumors: Incidence, Possible Pathogenesis and ManagementJournal of Urology, VOL. 138, NO. 2, (292-294), Online publication date: 1-Aug-1987.Catalona W (2018) Editorial CommentJournal of Urology, VOL. 138, NO. 2, (294-294), Online publication date: 1-Aug-1987.Hudson M, Ratliff T, Gillen D, Haaff E, Dresner S and Catalona W (2018) Single Course Versus Maintenance Bacillus Calmette-Guerin Therapy for Superficial Bladder Tumors: A Prospective, Randomized TrialJournal of Urology, VOL. 138, NO. 2, (295-298), Online publication date: 1-Aug-1987.DeKernion J (2018) Editorial CommentsJournal of Urology, VOL. 138, NO. 2, (298-298), Online publication date: 1-Aug-1987.Pansadoro V and De Paula F (2018) Intravesical Bacillus Calmette-Guerin in the Treatment of Superficial Transitional Cell Carcinoma of the BladderJournal of Urology, VOL. 138, NO. 2, (299-301), Online publication date: 1-Aug-1987.Stanisic T, Donovan J, Lebouton J and Graham A (2018) 5-Year Experience with Intravesical Therapy of Carcinoma in Situ: An Inquiry Into the Risks of "Conservative" ManagementJournal of Urology, VOL. 138, NO. 5, (1158-1161), Online publication date: 1-Nov-1987.Marans H and Bekirov H (2018) Granulomatous Hepatitis Following Intravesical Bacillus Calmette-guerin Therapy for Bladder CarcinomaJournal of Urology, VOL. 137, NO. 1, (111-112), Online publication date: 1-Jan-1987.Merguerian P, Donahue L and Cockett A (2018) Intraluminal Interleukin 2 and Bacillus Calmette-Guerin for Treatment of Bladder Cancer: A Preliminary ReportJournal of Urology, VOL. 137, NO. 2, (216-219), Online publication date: 1-Feb-1987.Catalona W, Hudson M, Gillen D, Andriole G and Ratliff T (2018) Risks and Benefits of Repeated Courses of Intravesical Bacillus Calmette-guerin Therapy for Superficial Bladder CancerJournal of Urology, VOL. 137, NO. 2, (220-224), Online publication date: 1-Feb-1987.Marsh C, Torrey R, Woolley J, Barker G and Lau B (2018) Superiority of Intravesical Immunotherapy with Corynebacterium Parvum and Allium Sativum in Control of Murine Bladder CancerJournal of Urology, VOL. 137, NO. 2, (359-362), Online publication date: 1-Feb-1987.Soloway M and Perry A (2018) Bacillus Calmette-Guerin for Treatment of Superficial Transitional Cell Carcinoma of the Bladder in Patients who have failed Thiotepa and/or Mitomycin CJournal of Urology, VOL. 137, NO. 5, (871-873), Online publication date: 1-May-1987.Catalona W (2018) Editorial CommentJournal of Urology, VOL. 137, NO. 5, (873-873), Online publication date: 1-May-1987. (2018) Reply by AuthorsJournal of Urology, VOL. 138, NO. 2, (294-294), Online publication date: 1-Aug-1987.Lamm D (2018) Editorial CommentsJournal of Urology, VOL. 138, NO. 2, (298-298), Online publication date: 1-Aug-1987. (2018) Reply by AuthorsJournal of Urology, VOL. 138, NO. 2, (298-298), Online publication date: 1-Aug-1987.Schellhammer P, Ladaga L and Fillion M (2018) Bacillus Calmette-Guerin for Superficial Transitional Cell Carcinoma of the BladderJournal of Urology, VOL. 135, NO. 2, (261-264), Online publication date: 1-Feb-1986.Herr H, Pinsky C, Whitmore W, Sogani P, Oettgen H and Melamed M (2018) Long-Term Effect of Intravesical Bacillus Calmette-Guerin on Flat Carcinoma in Situ of the BladderJournal of Urology, VOL. 135, NO. 2, (265-267), Online publication date: 1-Feb-1986.Droller M (2018) Bacillus Calmette-Guerin in the Management of Bladder CancerJournal of Urology, VOL. 135, NO. 2, (331-333), Online publication date: 1-Feb-1986.Stanisic T, Brewer M and Graham A (2018) Intravesical Bacillus Calmette-Guerin Therapy and Associated Granulomatous Renal MassesJournal of Urology, VOL. 135, NO. 2, (356-358), Online publication date: 1-Feb-1986.Lage J, Bauer W, Kelley D, Ratliff T and Catalona W (2018) Histological Parameters and Pitfalls in the Interpretation of Bladder Biopsies in Bacillus Calmette-Guerin Treatment of Superficial Bladder CancerJournal of Urology, VOL. 135, NO. 5, (916-919), Online publication date: 1-May-1986.Brosman S (2018) The Use of Bacillus Calmette-Guerin in the Therapy of Bladder Carcinoma in SituJournal of Urology, VOL. 134, NO. 1, (36-39), Online publication date: 1-Jul-1985. Volume 132Issue 3September 1984Page: 457-459 Advertisement Copyright & Permissions© 1984 by The American Urological Association Education and Research, Inc.MetricsAuthor Information Alvaro Morales More articles by this author Expand All Advertisement PDF DownloadLoading ...
Referência(s)